, which is organised by the Ministry of Education and attended by more than 1,500 school students, showcases the Ministry's educational vision to offer innovative and pioneering education for the UAE's future leaders.
Masdar was a participant in this year's NSTI
, which was held from January 31 to February 4 at Dubai Festival Arena.
In 2018, NSTI
celebrated 25 years of educating students about transportation and piquing their interest in college-level studies and career opportunities in the field.
The company has enrolled the first 200 patients under its ACCUTE trial to evaluate the novel candidate Reltecimod for the treatment of Necrotizing Soft Tissue Infections (Flesh Eating Bacteria).The phase 3 ACCUTE study is an ongoing randomized, placebo-controlled study, that plans to enroll 290 patients with NSTI
at 70 level 1 trauma sites in the US.
Bhubaneshwar [Odisha], July 17 ( ANI ): In an effort to meet the rising demand for skilled manpower, Ministry of Skill Development and Entrepreneurship has announced to launch the National Skill Training Institute (NSTI
) in Barang, Bhubaneswar.
Al Hammadi said, "At the second edition of NSTI
Festival we have made significant progress in the level of projects that have been submitted by students.
Launched on February 15 by the Ministry of Education as part of the UAE Innovation Month, at Dubai Festival Arena, the NSTI
features initiatives, activities and programmes that will run till 19th February, 2018.
The patient continued to clinically decline rapidly despite broadening of his antibiotic regimen (vancomycin, meropenem, gentamicin, and amphotericin B) and was taken to the operating room by the orthopedic surgery service due to concern of a rapidly progressing NSTI
Festival 2018 will also witness the launch of the first-of-its-kind Industrial Revolution X (IR-X) Program developed in partnership with a prominent international partner.
Though incidence of NSTI
is low, NSTIs
occur often enough that surgeons, physicians, infectious diseases specialists and others will encounter at least one patient with NSTI
during their practice.
AB103 is the first product specifically developed for NSTI
and has received Orphan Drug status and Fast Track designation from the FDA as well as a positive opinion from the EMA's Committee for Orphan Medicinal Products (COMP).